Literature DB >> 35721445

Cardioembolic stroke: An update on etiology, diagnosis and management.

Megan C Leary1, Louis R Caplan1.   

Abstract

Stroke and ischemic heart diseases are among the most common causes of death and disability throughout the world. Even more worrisome is the suggestion that stroke rates may further increase in certain developing nations. The purpose of this article is to review the particular subtype of stroke known as cardioembolic stroke. A cardioembolic stroke occurs when the heart pumps unwanted materials into the brain circulation, resulting in the occlusion of a brain blood vessel and damage to the brain tissue. The etiology, clinical manifestations, diagnosis and management of cardioembolic stroke are reviewed. Copyright:
© 2008 Annals of Indian Academy of Neurology.

Entities:  

Keywords:  Cardioembolic; diagnosis; etiology; ischemic; management; stroke

Year:  2008        PMID: 35721445      PMCID: PMC9204115     

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.714


  108 in total

Review 1.  Management of atrial fibrillation.

Authors:  E L Pritchett
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

2.  Prevalence of patent foramen ovale in patients with stroke.

Authors:  P Lechat; J L Mas; G Lascault; P Loron; M Theard; M Klimczac; G Drobinski; D Thomas; Y Grosgogeat
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

3.  Benign disappearance of ventricular thrombus after embolic stroke. A case report.

Authors:  L D DeWitt; M S Pessin; N G Pandian; S G Paulker; F A Sonnenberg; L R Caplan
Journal:  Stroke       Date:  1988-03       Impact factor: 7.914

Review 4.  The burden of cardiovascular disease in the Indian subcontinent.

Authors:  Abhinav Goyal; Salim Yusuf
Journal:  Indian J Med Res       Date:  2006-09       Impact factor: 2.375

5.  Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).

Authors:  Jonathan L Halperin
Journal:  Am Heart J       Date:  2003-09       Impact factor: 4.749

6.  Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.

Authors:  S M Wolpert; H Bruckmann; R Greenlee; L Wechsler; M S Pessin; G J del Zoppo
Journal:  AJNR Am J Neuroradiol       Date:  1993 Jan-Feb       Impact factor: 3.825

7.  A comparative study of coumadin and aspirin for primary cardioembolic stroke and thromboembolic preventions of chronic rheumatic mitral stenosis with atrial fibrillation.

Authors:  N Poungvarin; N Opartkiattikul; S Chaithiraphan; A Viriyavejakul
Journal:  J Med Assoc Thai       Date:  1994-01

8.  Striatocapsular infarction: large infarcts in the lenticulostriate arterial territory.

Authors:  P F Bladin; S F Berkovic
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910

9.  Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.

Authors: 
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

10.  Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome.

Authors:  D Toni; M Fiorelli; S Bastianello; M L Sacchetti; G Sette; C Argentino; E Montinaro; L Bozzao
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.